CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Amolyt Pharma

For profit

Also known as: Amolyt Pharma

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jun 7, 2023

Acquired by AstraZeneca on Mar 14, 2024

Timeline

2010s

Jun 1, 2014
Amolyt Pharma— Founded

2020s

Mar 14, 2024
AstraZeneca— Acquired By

Drugs by trial phase (1 distinct, 2 trials)

Phase 3 (1 own, 0 via acquisition)

azp-3601

Recent trials (3)

NCT05778071Lead sponsorPhase 3Jun 7, 2023
NCT05778071Study directorPhase 3Jun 7, 2023
NCT05239221Lead sponsorPhase 1Sep 7, 2020

Details

Founded: Ecully, FR Jun 1, 2014
Last known activity: Jun 7, 2023